Pseudodrynaria Coronana (Wall) Ching
Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00155675
Collaborator
Sheng Chang Pharmaceutical (Industry)
120
1
12
10
Study Details
Study Description
Brief Summary
The Study to evaluate the clinical effect of "Gusuibu" lasts for 3 years. It aims to evaluate its effect on bone density of postmenopausal osteoporosis. Besides, its effects on the liver, kidney and the hematological influence will be evaluated, too.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 1 |
Detailed Description
Research of the this traditional chinese medicine clinucal, Gusuibu, curative effect is plan three years time. The entire studyaims to evaluated the effect of the traditional chinese medicine on postmenpausal osteoporosis as well as the possible side effects on the experimental animal and the human body. All subjects were postmenopausal woman with established osteoporosis.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
120 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Clinical Effect of Traditional Chinese Medicine - "Gusuibu"
Study Start Date
:
Jan 1, 2000
Actual Study Completion Date
:
Jan 1, 2001
Outcome Measures
Primary Outcome Measures
- one year []
Eligibility Criteria
Criteria
Ages Eligible for Study:
45 Years
to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- postmenopausal osteoporosis
Exclusion Criteria:
- Insulin dependent diabetes
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National Taiwan University Medical Center | Taipei | 7, Chung-Shan S. Road | Taiwan | 100 |
Sponsors and Collaborators
- National Taiwan University Hospital
- Sheng Chang Pharmaceutical
Investigators
- Study Chair: Liu Hwa-Chang, M.D, National Taiwan University Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00155675
Other Study ID Numbers:
- 900505
- CCMP90-RD-114
First Posted:
Sep 12, 2005
Last Update Posted:
Jan 12, 2010
Last Verified:
Dec 1, 2009
Additional relevant MeSH terms: